-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on AC Immune, Maintains $8 Price Target

Benzinga·08/20/2026 14:30:04
語音播報
BTIG analyst Thomas Shrader reiterates AC Immune (NASDAQ:ACIU) with a Buy and maintains $8 price target.